This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses

SAN FRANCISCO, May 18, 2013 /PRNewswire-USNewswire/ -- The Open Paradigm Project, in collaboration with MadinAmerica.com , Occupy Psychiatry, and leading organizations in the movement to reform mental health care, announces a social media campaign showcasing video testimonials by individuals negatively impacted by the traditional psychiatric model, which focuses on pathology and illness rather than wellness and recovery. The launch coincides with the American Psychiatric Association's (APA) rollout of its latest revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), taking place at the APA's annual meeting in San Francisco this weekend. In light of National Institute of Mental Health (NIMH) director Thomas Insel's move away from the DSM ("lack of validity... patients deserve better") and DSM-5 task force chair David Kupfer's admission of an absence of biological markers of mental illness ("we're still waiting"), these stories starkly unveil the failure of, and harm done by, the prevailing model of mental health care.

These testimonials feature individuals whose meaningful, fulfilled lives – an outcome they attribute to rejecting psychiatric diagnoses they were told were incurable, and highly toxic treatments they were told would be life-long – demonstrate the dangers of a medicalized, manualized approach towards human suffering. Many reflect on years fruitlessly lost to "illnesses" they came to realize did not have a medical basis, and discuss alternative approaches that ultimately helped them embrace life's challenges and integrate these experiences into their lives.

The stories take on even greater significance in light of the controversies surrounding the newest edition of the DSM, as international public and professional communities openly question the biomedical standard of care. Lucy Johnstone, member of the Division of Clinical Psychology of the British Psychological Association says, "Traditionalists continue to claim that 'We're getting there – honestly!' In the meantime, the overwhelming amount of evidence for psychosocial causal factors (of distress) is once again relegated to a back seat." Even so, the NIMH's Research Domain Criteria (RDoC) and President Obama's BRAIN initiative have announced they will continue to look for solutions in biology –an approach that, despite decades of acknowledged failure, Insel proposes to be only "ten years away."

"Even the most painful struggles are part of the fabric of a meaningful life, not evidence of an illness," Open Paradigm producer PJ Moynihan explains. "These stories clearly reinforce that."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs